Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey D Kent

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Clinical Therapeutics|March 19, 2013
Budget impact modeling for a single-tablet formulation of ibuprofen and famotidine for prevention of upper gastrointestinal ulcers in patients with osteoarthritis and/or rheumatoid arthritisRenee Kuan, Robert J Holt, Kenneth E Johnson, et al.
Bulletin of the Hospital for Joint Disease (2013)|November 5, 2015
Improvement Thresholds for Morning Stiffness Duration in Patients Receiving Delayed- Versus Immediate-Release Prednisone for Rheumatoid ArthritisFrank Buttgereit, Jeffrey D Kent, Robert J Holt, et al.
Rheumatology and Therapy|October 18, 2016
Delays in Initiation of Disease-Modifying Therapy in Rheumatoid Arthritis Patients: Data from a US-Based RegistryDimitrios A Pappas, Jeffrey D Kent, Jeffrey D Greenberg, et al.
European Journal of Gastroenterology & Hepatology|October 4, 2002
Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritisDavid H Sikes, Naurang M Agrawal, William W Zhao, et al.
Hepatology (Baltimore, Md.)|February 22, 2005
Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascitesJoan Clària, Jeffrey D Kent, Marta López-Parra, et al.
Frontiers in Immunology|December 26, 2024
Linsitinib inhibits proliferation and induces apoptosis of both IGF-1R and TSH-R expressing cellsMaximilian Luffy, Anna-Lena Ganz, Stefanie Wagner, et al.
Transplantation Proceedings|July 2, 2019
Gout Severity in Recipients of Kidney TransplantMark D Brigham, Lauren P Radeck, Clive M Mendonca, et al.
Gastroenterology|January 24, 2007
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trialJean-Frédéric Colombel, William J Sandborn, Paul Rutgeerts, et al.
Annals of Transplantation|April 15, 2020
A Retrospective Cohort Study of the Effect of Gout on Mortality Among Patients with a History of Kidney TransplantationJustin W Li, Marissa Suh, Mark D Brigham, et al.
Annals of Internal Medicine|May 2, 2007
Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trialWilliam J Sandborn, Paul Rutgeerts, Robert Enns, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Clinical Therapeutics|March 19, 2013
Budget impact modeling for a single-tablet formulation of ibuprofen and famotidine for prevention of upper gastrointestinal ulcers in patients with osteoarthritis and/or rheumatoid arthritisRenee Kuan, Robert J Holt, Kenneth E Johnson, et al.
Bulletin of the Hospital for Joint Disease (2013)|November 5, 2015
Improvement Thresholds for Morning Stiffness Duration in Patients Receiving Delayed- Versus Immediate-Release Prednisone for Rheumatoid ArthritisFrank Buttgereit, Jeffrey D Kent, Robert J Holt, et al.
Rheumatology and Therapy|October 18, 2016
Delays in Initiation of Disease-Modifying Therapy in Rheumatoid Arthritis Patients: Data from a US-Based RegistryDimitrios A Pappas, Jeffrey D Kent, Jeffrey D Greenberg, et al.
European Journal of Gastroenterology & Hepatology|October 4, 2002
Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritisDavid H Sikes, Naurang M Agrawal, William W Zhao, et al.
Hepatology (Baltimore, Md.)|February 22, 2005
Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascitesJoan Clària, Jeffrey D Kent, Marta López-Parra, et al.
Frontiers in Immunology|December 26, 2024
Linsitinib inhibits proliferation and induces apoptosis of both IGF-1R and TSH-R expressing cellsMaximilian Luffy, Anna-Lena Ganz, Stefanie Wagner, et al.
Transplantation Proceedings|July 2, 2019
Gout Severity in Recipients of Kidney TransplantMark D Brigham, Lauren P Radeck, Clive M Mendonca, et al.
Gastroenterology|January 24, 2007
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trialJean-Frédéric Colombel, William J Sandborn, Paul Rutgeerts, et al.
Annals of Transplantation|April 15, 2020
A Retrospective Cohort Study of the Effect of Gout on Mortality Among Patients with a History of Kidney TransplantationJustin W Li, Marissa Suh, Mark D Brigham, et al.
Annals of Internal Medicine|May 2, 2007
Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trialWilliam J Sandborn, Paul Rutgeerts, Robert Enns, et al.
Pageof 3